Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KRYS | BMRN | CYTK | ||
| Company | Krystal Biotech Inc | Biomarin Pharmaceuticals | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 356.49 | 55.51 | 80.00 | ||
| High | 356.49 | 56.31 | 80.80 | ||
| Low | 341.66 | 54.96 | 78.36 | ||
| Latest | 343.43 | 55.90 | 79.17 | ||
| Change | -4.63 | +1.21 | +0.39 | ||
| % Change | -1.33% | +2.21% | +0.50% | ||
| Volume | 411,600 | 3,014,500 | 2,888,300 | ||
| 20-Day Average Volume | 308,560 | 2,338,750 | 1,982,500 | ||
| Previous Close | 348.06 | 54.69 | 78.78 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 313.74 | 55.21 | 73.43 | ||
| 20-Day Raw Stochastic | 81.70% | 61.09% | 88.50% | ||
| 20-Day Relative Strength | 67.00 | 52.80 | 61.48 | ||
| Weighted Alpha | +145.01 | +0.51 | +83.03 | ||
| Today's Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.01% since 06/12/26 | -0.09% since 06/12/26 | +12.86% since 06/12/26 | ||
| Low | 314.00 on 06/15/26 | 54.26 on 06/18/26 | 68.84 on 06/15/26 | ||
| High | 356.50 on 06/18/26 | 56.35 on 06/15/26 | 80.80 on 06/22/26 | ||
| 1-Month | |||||
| %Chg | +14.69% since 05/22/26 | +3.35% since 05/22/26 | +2.90% since 05/22/26 | ||
| Low | 285.07 on 06/02/26 | 52.19 on 05/28/26 | 66.63 on 06/10/26 | ||
| High | 356.50 on 06/18/26 | 58.26 on 06/10/26 | 80.80 on 06/22/26 | ||
| 3-Month | |||||
| %Chg | +36.46% since 03/20/26 | +3.27% since 03/20/26 | +28.31% since 03/20/26 | ||
| Low | 242.00 on 03/31/26 | 49.26 on 05/18/26 | 58.65 on 04/29/26 | ||
| High | 356.50 on 06/18/26 | 58.26 on 06/10/26 | 80.80 on 06/22/26 | ||
| 6-Month | |||||
| %Chg | +37.59% since 12/22/25 | -5.70% since 12/22/25 | +20.69% since 12/22/25 | ||
| Low | 235.60 on 01/05/26 | 49.26 on 05/18/26 | 58.43 on 03/13/26 | ||
| High | 356.50 on 06/18/26 | 66.28 on 02/24/26 | 80.80 on 06/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,260,805 | 10,570,701 | 9,802,831 | ||
| Shares Outstanding, K | 29,480 | 193,284 | 124,433 | ||
| Annual Sales | 389,130,000 | 3,221,250,000 | 88,040,000 | ||
| Annual Net Income | 204,830,000 | 348,900,000 | -784,960,000 | ||
| Last Quarter Sales | 116,360,000 | 766,210,000 | 19,360,000 | ||
| Last Quarter Net Income | 55,930,000 | 105,530,000 | -206,030,000 | ||
| 60-Month Beta | 0.53 | 0.25 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.83 on 05/04/26 | 0.76 on 05/04/26 | -1.67 on 05/05/26 | ||
| Earnings Date | 08/03/26 | 08/03/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 45.68 | 27.10 | 0.00 | ||